S'abonner

The Association of Red Blood Cell Transfusion with Mortality in Pediatric Patients with Sepsis, Severe Sepsis, and Septic Shock: a single-center retrospective cohort study - 20/12/24

Doi : 10.1016/j.tracli.2024.12.002 
Mingwei Yin a, Ting Wang b, Qian Jiang a, Xinli Qu c, Jihua Ma a, Jun Xu a, Xiaobo Jin a, Xuejun Chen a,
a Department of Blood Transfusion, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, Zhejiang Province, P.R. China 
b Department of Blood Transfusion, Tai’an Traditional Chinese Medicine Hospital, Tai’an, Shandong Province, P.R. China 
c School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, P.R. China 

Corresponding author.
Sous presse. Manuscrit accepté. Disponible en ligne depuis le Friday 20 December 2024

Highlights

Lower hemoglobin level, increased CRP level, and lower platelets count are related to the RBC transfusion in pediatric patients with sepsis, severe sepsis, and septic shock.
RBC transfusions are significantly associated with increased ICU length of stay and not associated with 28-day mortality and mechanical ventilation rate.
Younger age, use of mechanical ventilation, and more severe disease are associated with increased mortality in pediatric patients with sepsis, severe sepsis, and septic shock.

Le texte complet de cet article est disponible en PDF.

Abstract

Background/Objectives:

Pediatric patients with sepsis are frequently subjected to red blood cell (RBC) transfusions but yet its association with mortality is still controversial.

Methods

We consecutively selected 125 patients with sepsis, severe sepsis, and septic shock admitted to intensive care unit (ICU) in our center from January 2022 to January 2023, and finally 100 patients were included in this retrospective cohort study. The patients were divided into two groups: group I who received RBC transfusion and group II who did not receive RBC transfusion. Logistic regression analysis was used to determine the demographic and clinical factors related to receiving RBC transfusion. The association of RBC transfusion with mortality was determined by the Cox regression model, and the mechanical ventilation rate and length of stay by the logistic regression model.

Results

Among the 100 patients, 67 and 33 cases belonged to the RBC-transfused and not-transfused groups, respectively. Lower hemoglobin level (OR=0.918, 95%CI: 0.881-0.957, p < 0.001), increased c-reactive protein level (OR=1.022, 95%CI: 1.002-1.043, p = 0.034), and lower platelets count (OR=0.994, 95%CI: 0.988-0.999, p = 0.023) were associated with RBC transfusions. While the associations of RBC transfusion with mortality and mechanical ventilation were not shown to be statistically significant (HR=3.926, 95%CI: 0.952-16.186, p = 0.058 and OR=2.588, 95%CI: 0.832-8.046, p = 0.1), RBC transfusion might be associated with increased ICU length of stay (OR=16.477, 95%CI: 3.86-70.342, p < 0.001). In the overall survival analysis, younger age (HR=0.093, 95%CI: 0.027-0.320, p < 0.001), the use of mechanical ventilation (HR=8.893, 95%CI: 1.483-53.336, p=0.017), and more severe disease (severe sepsis vs. sepsis, HR=24.531, 95%CI: 1.923-321.914, p=0.014; septic shock vs. sepsis, HR=32.187, 95%CI: 2.977-347.949, p=0.004) were related to increased mortality.

Conclusions

RBC transfusions are significantly associated with increased ICU length of stay and not associated with 28-day mortality and mechanical ventilation rate. Other factors affecting mortality in pediatric patients with sepsis, severe sepsis, and septic shock are younger age, use of mechanical ventilation, and more severe disease.

Le texte complet de cet article est disponible en PDF.

Keywords : RBC transfusion, pediatrics, sepsis, mortality


Plan


© 2024  Société francophone de transfusion sanguine (SFTS). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.